Dr. Andrew M. Bernstein, DO

Dr. Bernstein practices at Regional Cancer Care Associates in Riverdale, New Jersey.

Dr. Bernstein's NPI, 1669490975, was assigned on July 17, 2006. Dr. Bernstein graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1999. Dr. Bernstein holds New Jersey license 25MB08035400.

Dr. Bernstein's primary practice is Regional Cancer Care Associates, at 18 Newark Pompton Turnpike, Riverdale, NJ 07457 in Morris County. The practice phone is (732) 367-1535.

Dr. Bernstein's primary practice is Regional Cancer Care Associates in Riverdale, New Jersey. Dr. Bernstein is also affiliated with Morristown Medical Center. The medical group on file is Regional Cancer Care Associates. Dmand AI also links Dr. Bernstein to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernstein practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bernstein's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bernstein is board certified in hematology by the American Board of Internal Medicine. Dr. Bernstein is licensed in New Jersey.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Bernstein treats.

CMS data shows 74,585 Medicare services from Dr. Bernstein across 38 procedure codes in 2024, for 623 Medicare patients. Medicare paid $846,007 for them. Every service was in an office.

CMS counts 623 Medicare patients who saw Dr. Bernstein in 2024. The largest group is 75 to 84, with 246 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bernstein's median patient age at 71, with 59% women.

In 2024, Dr. Bernstein wrote 126 Medicare Part D claims for 63 patients. 93% of them were for generic drugs. CMS names the drug for 57 of them, across 3 drugs with 11 or more claims each, at $1,313 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Bernstein for performance year 2024, reported as part of a group. Dr. Bernstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 125 general payments to Dr. Bernstein from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Amgen Inc. paid the most, $527.

Dmand AI lists 1 award for Dr. Bernstein, most recently CMS Stage 1 EHR in 2013.

Dr. Bernstein graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1999.

Dr. Bernstein is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.